These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 24407579

  • 1. Protection against squamous cell carcinoma and cervical adenocarcinoma afforded by cervical cytology screening: a cross-sectional study.
    Vale DB, Braganca JF, Morais SS, Zeferino LC.
    Int J Gynecol Cancer; 2014 Feb; 24(2):321-8. PubMed ID: 24407579
    [Abstract] [Full Text] [Related]

  • 2. High-grade squamous intraepithelial lesion in women aged <30 years has a prevalence pattern resembling low-grade squamous intraepithelial lesion.
    Vale DB, Westin MC, Zeferino LC.
    Cancer Cytopathol; 2013 Oct; 121(10):576-81. PubMed ID: 23765869
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?
    Jackson R, Wang L, Jembere N, Murphy J, Kupets R.
    J Low Genit Tract Dis; 2019 Jan; 23(1):1-6. PubMed ID: 30489433
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the diagnostic value of cervical cytology and HPV HR DNA testing for the diagnosis of low-grade and high-grade squamous intraepithelial lesions across different age groups.
    Paluszkiewicz A, Pruski D, Iwaniec K, Kędzia W.
    Ginekol Pol; 2017 Jan; 88(3):141-146. PubMed ID: 28397203
    [Abstract] [Full Text] [Related]

  • 8. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ, Keane DP, Flannelly GM, Lenehan PM, Murphy JF, Foley ME.
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B, Kemetli L, Sparén P, Silfverdal L, Strander B, Ryd W, Dillner J, Törnberg S.
    J Natl Cancer Inst; 2008 May 07; 100(9):622-9. PubMed ID: 18445828
    [Abstract] [Full Text] [Related]

  • 12. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.
    Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, DʼSouza G.
    AIDS; 2017 Apr 24; 31(7):1035-1044. PubMed ID: 28323758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
    van der Horst J, Siebers AG, Bulten J, Massuger LF, de Kok IM.
    Cancer Med; 2017 Feb 24; 6(2):416-423. PubMed ID: 28102052
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.